Report date: Apr 30, 2024
Conflict count: 350192
Publisher: Oxford University Press
Title count: 218
Conflict count: 9353


==========================================================

Created: 2017-10-13 05:59:02.0
ConfID: 4975344
CauseID: 1415919399
OtherID: 63385536, 233345263, 1415919399
JT: Neuro-Oncology
MD: Cheng, 2 ,2,87,2000,Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy
DOI: 10.1215/S1522851799000447(Journal) (4975344-N )
DOI: 10.1093/neuonc/2.2.87(Journal)
==========================================================

Created: 2010-08-31 16:10:44.0
ConfID: 4975358
CauseID: 1207793912
OtherID: 63385536, 1207793912
JT: Neuro-Oncology
MD: Bigner, 4 ,4,241,2002,Editorial
DOI: 10.1215/S1522851702200034(Journal) (4975358-N )
DOI: 10.1093/neuonc/4.4.241(Journal)
==========================================================

Created: 2017-10-13 16:24:03.0
ConfID: 4975412
CauseID: 1415944011
OtherID: 63385536, 1415944011
JT: Neuro-Oncology
MD: Cohen, 4 ,2,129,2002,Intractable vomiting from glioblastoma metastatic to the fourth ventricle: Three case studies
DOI: 10.1215/S1522851701000539(Journal) (4975412-N )
DOI: 10.1093/neuonc/4.2.129(Journal)
==========================================================

Created: 2017-10-13 16:23:57.0
ConfID: 4975446
CauseID: 1415944010
OtherID: 63385536, 233345263, 1415944010
JT: Neuro-Oncology
MD: Newsham, 2 ,1,1,2000,Use of horizontal ultrathin gel electrophoresis to analyze allelic deletions in chromosome band 11p15.5 in gliomas
DOI: 10.1215/S1522851799000149(Journal) (4975446-N )
DOI: 10.1093/neuonc/2.1.1(Journal)
==========================================================

Created: 2017-10-13 16:16:22.0
ConfID: 4985230
CauseID: 1415943792
OtherID: 63385536, 233345263, 1415943792
JT: Neuro-Oncology
MD: Robins, 4 ,2,109,2002,A phase II trial of thymidine and carboplatin for recurrent malignant glioma: A North American Brain Tumor Consortium Study
DOI: 10.1215/S1522851701000515(Journal) (4985230-N )
DOI: 10.1093/neuonc/4.2.109(Journal)
==========================================================

Created: 2017-10-13 14:52:55.0
ConfID: 4985231
CauseID: 1415940367
OtherID: 63385536, 1415940367
JT: Neuro-Oncology
MD: Kamitani, 4 ,2,95,2002,Histone acetylation may suppress human glioma cell proliferation when p21WAF/Cip1 and gelsolin are induced
DOI: 10.1215/S1522851701000564(Journal) (4985231-N )
DOI: 10.1093/neuonc/4.2.95(Journal)
==========================================================

Created: 2017-10-13 04:20:46.0
ConfID: 4985338
CauseID: 1415914124
OtherID: 63385536, 233345263, 1415914124
JT: Neuro-Oncology
MD: Collins, 1 ,3,221,1999,CNS tumors and exposure to acrylonitrile: Inconsistency between experimental and epidemiology studies
DOI: 10.1215/S1522851799000101(Journal) (4985338-N )
DOI: 10.1093/neuonc/1.3.221(Journal)
==========================================================

Created: 2017-10-13 05:07:09.0
ConfID: 4985375
CauseID: 1415916480
OtherID: 63385536, 1415916480
JT: Neuro-Oncology
MD: Bodell, 3 ,4,241,2001,Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors
DOI: 10.1215/S1522851701000035(Journal) (4985375-N )
DOI: 10.1093/neuonc/3.4.241(Journal)
==========================================================

Created: 2017-10-13 04:02:27.0
ConfID: 4985376
CauseID: 1415913251
OtherID: 63385536, 233345263, 1415913251
JT: Neuro-Oncology
MD: Biagi, 2 ,4,239,2000,Primary Hodgkin''s disease of the CNS in an immunocompetent patient: A case study and review of the literature
DOI: 10.1215/S1522851700000284(Journal) (4985376-N )
DOI: 10.1093/neuonc/2.4.239(Journal)
==========================================================

Created: 2017-10-13 14:42:11.0
ConfID: 4985377
CauseID: 1415940152
OtherID: 63385536, 1415940152
JT: Neuro-Oncology
MD: Gilbert, 4 ,4,261,2002,A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy
DOI: 10.1215/S1522851702000091(Journal) (4985377-N )
DOI: 10.1093/neuonc/4.4.261(Journal)
==========================================================

Created: 2017-10-13 15:43:52.0
ConfID: 4993400
CauseID: 1415942731
OtherID: 63385536, 233345263, 1415942731
JT: Neuro-Oncology
MD: Giordana, 4 ,2,115,2002,MDM2 overexpression is associated with short survival in adults with medulloblastoma
DOI: 10.1215/S152285170100062X(Journal) (4993400-N )
DOI: 10.1093/neuonc/4.2.115(Journal)
==========================================================

Created: 2017-10-13 15:44:32.0
ConfID: 4993467
CauseID: 1415942752
OtherID: 63385536, 1415942752
JT: Neuro-Oncology
MD: Groothuis, 2 ,1,45,2000,The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
DOI: 10.1215/S1522851799000307(Journal) (4993467-N )
DOI: 10.1093/neuonc/2.1.45(Journal)
==========================================================

Created: 2017-10-13 13:18:51.0
ConfID: 4993496
CauseID: 1415936343
OtherID: 63385536, 233345263, 1415936343
JT: Neuro-Oncology
MD: Giese, 1 ,1,3,1999,Thromboxane synthase regulates the migratory phenotype of human glioma cells
DOI: 10.1215/S1522851798000143(Journal) (4993496-N )
DOI: 10.1093/neuonc/1.1.3(Journal)
==========================================================

Created: 2012-03-13 11:13:39.0
ConfID: 5002823
CauseID: 1349651443
OtherID: 63385536, 1349651443
JT: Neuro-Oncology
MD: Bigner, 1 ,1,1,1999,Editorial
DOI: 10.1215/S1522851798000258(Journal) (5002823-N )
DOI: 10.1093/neuonc/1.1.1(Journal)
==========================================================

Created: 2017-10-13 08:27:09.0
ConfID: 5006321
CauseID: 1415926663
OtherID: 63385536, 233345263, 1415926663
JT: Neuro-Oncology
MD: Prados, 5 ,2,96,2003,A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma
DOI: 10.1215/S1522851702000340(Journal) (5006321-N )
DOI: 10.1093/neuonc/5.2.96(Journal)
==========================================================

Created: 2017-10-13 15:31:41.0
ConfID: 5006336
CauseID: 1415942278
OtherID: 63385536, 1415942278
JT: Neuro-Oncology
MD: Lang, 4 ,4,268,2002,Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies
DOI: 10.1215/S1522851702000121(Journal) (5006336-N )
DOI: 10.1093/neuonc/4.4.268(Journal)
==========================================================

Created: 2017-10-13 05:03:59.0
ConfID: 5006341
CauseID: 1415916363
OtherID: 63385536, 233345263, 1415916363
JT: Neuro-Oncology
MD: Wooten, 1 ,3,169,1999,A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution
DOI: 10.1215/S1522851798000283(Journal) (5006341-N )
DOI: 10.1093/neuonc/1.3.169(Journal)
==========================================================

Created: 2017-10-13 11:19:56.0
ConfID: 5006388
CauseID: 1415932936
OtherID: 63385536, 1415932936
JT: Neuro-Oncology
MD: Duffner, 1 ,2,152,1999,The treatment of malignant brain tumors in infants and very young children: An update of the Pediatric Oncology Group experience
DOI: 10.1215/S1522851798000313(Journal) (5006388-N )
DOI: 10.1093/neuonc/1.2.152(Journal)
==========================================================

Created: 2017-10-13 14:47:34.0
ConfID: 5006390
CauseID: 1415940274
OtherID: 63385536, 233345263, 1415940274
JT: Neuro-Oncology
MD: Kramer, 3 ,3,211,2001,Electronic research: An opportunity for the Society for Neuro-Oncology
DOI: 10.1215/S152285170000065X(Journal) (5006390-N )
DOI: 10.1093/neuonc/3.3.211(Journal)
==========================================================

Created: 2017-10-13 04:56:47.0
ConfID: 5006391
CauseID: 1415916014
OtherID: 63385536, 1415916014
JT: Neuro-Oncology
MD: Bartleson, 5 ,2,121,2003,Reversible, strokelike migraine attacks in patients with previous radiation therapy
DOI: 10.1215/S1522851702000406(Journal) (5006391-N )
DOI: 10.1093/neuonc/5.2.121(Journal)
==========================================================

Created: 2017-10-13 18:28:18.0
ConfID: 5006402
CauseID: 1415947463
OtherID: 63385536, 233345263, 1415947463
JT: Neuro-Oncology
MD: Hochberg, 2 ,1,29,2000,Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma
DOI: 10.1215/S1522851799000162(Journal) (5006402-N )
DOI: 10.1093/neuonc/2.1.29(Journal)
==========================================================

Created: 2017-10-13 04:20:29.0
ConfID: 5006403
CauseID: 1415914115
OtherID: 63385536, 233345263, 1415914115
JT: Neuro-Oncology
MD: Merchant, 1 ,3,177,1999,Preliminary results of conformal radiation therapy for medulloblastoma
DOI: 10.1215/S1522851798000015(Journal) (5006403-N )
DOI: 10.1093/neuonc/1.3.177(Journal)
==========================================================

Created: 2017-10-13 12:59:20.0
ConfID: 5015876
CauseID: 1415935760
OtherID: 63385536, 1415935760
JT: Neuro-Oncology
MD: Hirano, 1 ,2,109,1999,Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas
DOI: 10.1215/S1522851798000167(Journal) (5015876-N )
DOI: 10.1093/neuonc/1.2.109(Journal)
==========================================================

Created: 2017-10-13 13:23:50.0
ConfID: 5015877
CauseID: 1415936447
OtherID: 63385536, 233345263, 1415936447
JT: Neuro-Oncology
MD: null, 1 ,1,27,1999,Pediatric Brain Tumor Foundation Of The United States: Supporting The Search For The Cause And Cure Of Childhood Brain Tumors
DOI: 10.1215/S1522851798000064(Journal) (5015877-N )
DOI: 10.1093/neuonc/1.1.27(Journal)
==========================================================

Created: 2017-10-13 08:15:10.0
ConfID: 5015879
CauseID: 1415926122
OtherID: 63385536, 1415926122
JT: Neuro-Oncology
MD: Korones, 5 ,2,116,2003,Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?
DOI: 10.1215/S1522851702000303(Journal) (5015879-N )
DOI: 10.1093/neuonc/5.2.116(Journal)
==========================================================

Created: 2017-10-13 04:32:59.0
ConfID: 5015880
CauseID: 1415914759
OtherID: 63385536, 233345263, 1415914759
JT: Neuro-Oncology
MD: Osoba, 2 ,4,221,2000,Effect of disease burden on health-related quality of life in patients with malignant gliomas
DOI: 10.1215/S1522851799000551(Journal) (5015880-N )
DOI: 10.1093/neuonc/2.4.221(Journal)
==========================================================

Created: 2017-10-13 13:16:55.0
ConfID: 5015881
CauseID: 1415936304
OtherID: 63385536, 1415936304
JT: Neuro-Oncology
MD: Raithatha, 2 ,3,145,2000,Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas
DOI: 10.1215/S1522851799000496(Journal) (5015881-N )
DOI: 10.1093/neuonc/2.3.145(Journal)
==========================================================

Created: 2017-10-13 17:00:15.0
ConfID: 5015882
CauseID: 1415944982
OtherID: 63385536, 1415944982
JT: Neuro-Oncology
MD: Glass, 2 ,3,151,2000,Inhibition of cell growth in human glioblastoma cell lines by farnesyltransferase inhibitor SCH66336
DOI: 10.1215/S152285170000020X(Journal) (5015882-N )
DOI: 10.1093/neuonc/2.3.151(Journal)
==========================================================

Created: 2017-10-13 14:42:54.0
ConfID: 5015898
CauseID: 1415940166
OtherID: 63385536, 1415940166
JT: Neuro-Oncology
MD: Wrensch, 4 ,4,278,2002,Epidemiology of primary brain tumors: Current concepts and review of the literature
DOI: 10.1215/S152285170200011X(Journal) (5015898-N )
DOI: 10.1093/neuonc/4.4.278(Journal)
==========================================================

Created: 2017-10-13 19:52:11.0
ConfID: 5015899
CauseID: 1415950048
OtherID: 63385536, 233345263, 1415950048
JT: Neuro-Oncology
MD: Sembritzki, 4 ,3,171,2002,Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein
DOI: 10.1215/S1522851701000552(Journal) (5015899-N )
DOI: 10.1093/neuonc/4.3.171(Journal)
==========================================================

Created: 2017-10-13 11:01:26.0
ConfID: 5015902
CauseID: 1415932374
OtherID: 63385536, 233345263, 1415932374
JT: Neuro-Oncology
MD: Comas, 1 ,4,261,1999,Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors
DOI: 10.1215/S1522851798000271(Journal) (5015902-N )
DOI: 10.1093/neuonc/1.4.261(Journal)
==========================================================

Created: 2017-10-13 04:25:11.0
ConfID: 5015945
CauseID: 1415914278
OtherID: 63385536, 1415914278
JT: Neuro-Oncology
MD: Hassall, 3 ,4,251,2001,Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: Three case studies and a review of the literature
DOI: 10.1215/S1522851701000278(Journal) (5015945-N )
DOI: 10.1093/neuonc/3.4.251(Journal)
==========================================================

Created: 2017-10-13 16:06:15.0
ConfID: 5015946
CauseID: 1415943377
OtherID: 63385536, 233345263, 1415943377
JT: Neuro-Oncology
MD: Sanghavi, 5 ,1,8,2003,A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: First report of the Children''s Cancer Group-0952
DOI: 10.1215/S1522851702000108(Journal) (5015946-N )
DOI: 10.1093/neuonc/5.1.8(Journal)
==========================================================

Created: 2017-10-13 12:44:52.0
ConfID: 5023851
CauseID: 1415935385
OtherID: 63385536, 233345263, 1415935385
JT: Neuro-Oncology
MD: Bigner, 1 ,1,52,1999,Morphologic and molecular genetic aspects of oligodendroglial neoplasms
DOI: 10.1215/S1522851798000209(Journal) (5023851-N )
DOI: 10.1093/neuonc/1.1.52(Journal)
==========================================================

Created: 2017-10-13 18:16:51.0
ConfID: 5023852
CauseID: 1415947197
OtherID: 63385536, 1415947197
JT: Neuro-Oncology
MD: Sands, 3 ,3,174,2001,Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor Study
DOI: 10.1215/S152285170000051X(Journal) (5023852-N )
DOI: 10.1093/neuonc/3.3.174(Journal)
==========================================================

Created: 2017-10-13 16:55:35.0
ConfID: 5023868
CauseID: 1415944881
OtherID: 63385536, 1415944881
JT: Neuro-Oncology
MD: Woods, 4 ,4,242,2002,Phosphatidylinositol 3''-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells
DOI: 10.1215/S1522851702000030(Journal) (5023868-N )
DOI: 10.1093/neuonc/4.4.242(Journal)
==========================================================

Created: 2017-10-13 18:10:05.0
ConfID: 5023869
CauseID: 1415946927
OtherID: 63385536, 1415946927
JT: Neuro-Oncology
MD: Eley, 4 ,2,86,2002,A chromosomal region 7p11.2 transcript map: Its development and application to the study of EGFR amplicons in glioblastoma
DOI: 10.1215/S1522851701000576(Journal) (5023869-N )
DOI: 10.1093/neuonc/4.2.86(Journal)
==========================================================

Created: 2017-10-13 18:21:33.0
ConfID: 5030478
CauseID: 1415947315
OtherID: 63385536, 233345263, 1415947315
JT: Neuro-Oncology
MD: Shu, 2 ,1,16,2000,Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation
DOI: 10.1215/S1522851799000368(Journal) (5030478-N )
DOI: 10.1093/neuonc/2.1.16(Journal)
==========================================================

Created: 2017-10-13 15:27:13.0
ConfID: 5030523
CauseID: 1415941810
OtherID: 63385536, 233345263, 1415941810
JT: Neuro-Oncology
MD: Jackson, 3 ,3,193,2001,Limitations of stereotactic biopsy in the initial management of gliomas
DOI: 10.1215/S1522851701000011(Journal) (5030523-N )
DOI: 10.1093/neuonc/3.3.193(Journal)
==========================================================

Created: 2017-10-13 16:45:45.0
ConfID: 5030524
CauseID: 1415944671
OtherID: 63385536, 233345263, 1415944671
JT: Neuro-Oncology
MD: Ueda, 5 ,1,14,2003,Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis
DOI: 10.1215/S1522851702000169(Journal) (5030524-N )
DOI: 10.1093/neuonc/5.1.14(Journal)
==========================================================

Created: 2017-10-13 13:17:01.0
ConfID: 5030525
CauseID: 1415936306
OtherID: 63385536, 1415936306
JT: Neuro-Oncology
MD: Frederick, 2 ,3,159,2000,Analysis of genomic rearrangements associated with EGFRvIII expression suggests involvement of Alu repeat elements
DOI: 10.1215/S1522851700000193(Journal) (5030525-N )
DOI: 10.1093/neuonc/2.3.159(Journal)
==========================================================

Created: 2017-10-13 17:40:15.0
ConfID: 5030550
CauseID: 1415946233
OtherID: 63385536, 233345263, 1415946233
JT: Neuro-Oncology
MD: Kuriyama, 4 ,3,179,2002,Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas
DOI: 10.1215/S1522851701000424(Journal) (5030550-N )
DOI: 10.1093/neuonc/4.3.179(Journal)
==========================================================

Created: 2017-10-13 16:49:34.0
ConfID: 5036214
CauseID: 1415944756
OtherID: 63385536, 233345263, 1415944756
JT: Neuro-Oncology
MD: Fouladi, 3 ,3,184,2001,Pleomorphic xanthoastrocytoma: Favorable outcome after complete surgical resection
DOI: 10.1215/S1522851700000685(Journal) (5036214-N )
DOI: 10.1093/neuonc/3.3.184(Journal)
==========================================================

Created: 2017-10-13 04:20:34.0
ConfID: 5036223
CauseID: 1415914118
OtherID: 63385536, 233345263, 1415914118
JT: Neuro-Oncology
MD: O''Neill, 1 ,3,196,1999,The consequences of treatment and disease in patients with primary CNS non-Hodgkin''s lymphoma: Cognitive function and performance status
DOI: 10.1215/S1522851798000246(Journal) (5036223-N )
DOI: 10.1093/neuonc/1.3.196(Journal)
==========================================================

Created: 2017-10-13 14:00:35.0
ConfID: 5036251
CauseID: 1415937493
OtherID: 63385536, 1415937493
JT: Neuro-Oncology
MD: Chiou, 3 ,3,159,2001,Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy
DOI: 10.1215/S1522851700000491(Journal) (5036251-N )
DOI: 10.1093/neuonc/3.3.159(Journal)
==========================================================

Created: 2017-10-13 13:47:35.0
ConfID: 5036252
CauseID: 1415937135
OtherID: 63385536, 1415937135
JT: Neuro-Oncology
MD: Kunschner, 3 ,3,167,2001,Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998
DOI: 10.1215/S1522851700000582(Journal) (5036252-N )
DOI: 10.1093/neuonc/3.3.167(Journal)
==========================================================

Created: 2017-10-13 10:34:42.0
ConfID: 5036253
CauseID: 1415931195
OtherID: 63385536, 233345263, 1415931195
JT: Neuro-Oncology
MD: Catania, 3 ,2,89,2001,Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells
DOI: 10.1215/S1522851700000387(Journal) (5036253-N )
DOI: 10.1093/neuonc/3.2.89(Journal)
==========================================================

Created: 2017-10-13 21:29:05.0
ConfID: 5036254
CauseID: 1415954300
OtherID: 63385536, 233345263, 1415954300
JT: Neuro-Oncology
MD: Levin, 2 ,1,22,2000,Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children
DOI: 10.1215/S1522851799000095(Journal) (5036254-N )
DOI: 10.1093/neuonc/2.1.22(Journal)
==========================================================

Created: 2017-10-13 15:08:25.0
ConfID: 5040915
CauseID: 1415941010
OtherID: 63385536, 1415941010
JT: Neuro-Oncology
MD: Aldosari, 4 ,2,75,2002,Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft
DOI: 10.1215/S1522851701000059(Journal) (5040915-N )
DOI: 10.1093/neuonc/4.2.75(Journal)
==========================================================

Created: 2017-10-13 04:50:01.0
ConfID: 5040928
CauseID: 1415915766
OtherID: 63385536, 233345263, 1415915766
JT: Neuro-Oncology
MD: Puzzilli, 1 ,3,188,1999,Anterior clinoidal meningiomas: Report of a series of 33 patients operated on through the pterional approach
DOI: 10.1215/S1522851798000210(Journal) (5040928-N )
DOI: 10.1093/neuonc/1.3.188(Journal)
==========================================================

Created: 2017-10-13 04:49:53.0
ConfID: 5040929
CauseID: 1415915763
OtherID: 63385536, 233345263, 1415915763
JT: Neuro-Oncology
MD: Gurney, 1 ,3,212,1999,Extremely low frequency electromagnetic fields (EMF) and brain cancer in adults and children: Review and comment
DOI: 10.1215/S1522851799000113(Journal) (5040929-N )
DOI: 10.1093/neuonc/1.3.212(Journal)
==========================================================

Created: 2017-10-13 05:43:41.0
ConfID: 5040950
CauseID: 1415918761
OtherID: 63385536, 1415918761
JT: Neuro-Oncology
MD: Cairncross, 2 ,2,114,2000,Myeloablative chemotherapy for recurrent aggressive oligodendroglioma
DOI: 10.1215/S1522851799000541(Journal) (5040950-N )
DOI: 10.1093/neuonc/2.2.114(Journal)
==========================================================

Created: 2017-10-13 12:51:48.0
ConfID: 5044925
CauseID: 1415935580
OtherID: 63385536, 233345263, 1415935580
JT: Neuro-Oncology
MD: de Winter, 1 ,4,275,1999,Brain tumors in children with neurofibromatosis: Additional neuropsychological morbidity?
DOI: 10.1215/S1522851799000058(Journal) (5044925-N )
DOI: 10.1093/neuonc/1.4.275(Journal)
==========================================================

Created: 2017-10-13 15:20:31.0
ConfID: 5044967
CauseID: 1415941665
OtherID: 63385536, 1415941665
JT: Neuro-Oncology
MD: Pipas, 2 ,3,190,2000,Treatment of progressive metastatic glomus jugulare tumor (paraganglioma) with gemcitabine
DOI: 10.1215/S1522851700000120(Journal) (5044967-N )
DOI: 10.1093/neuonc/2.3.190(Journal)
==========================================================

Created: 2017-10-13 04:20:41.0
ConfID: 5048397
CauseID: 1415914121
OtherID: 63385536, 233345263, 1415914121
JT: Neuro-Oncology
MD: Davis, 1 ,3,205,1999,Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base
DOI: 10.1215/S1522851798000222(Journal) (5048397-N )
DOI: 10.1093/neuonc/1.3.205(Journal)
==========================================================

Created: 2017-10-13 06:04:15.0
ConfID: 5048398
CauseID: 1415920009
OtherID: 63385536, 1415920009
JT: Neuro-Oncology
MD: van den Bent, 5 ,2,128,2003,Recent developments in the molecular characterization and treatment of oligodendroglial tumors
DOI: 10.1215/S1522851702000285(Journal) (5048398-N )
DOI: 10.1093/neuonc/5.2.128(Journal)
==========================================================

Created: 2017-10-13 15:28:58.0
ConfID: 5048401
CauseID: 1415941846
OtherID: 63385536, 233345263, 1415941846
JT: Neuro-Oncology
MD: Turner, 4 ,2,102,2002,Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: The Duke experience
DOI: 10.1215/S1522851701000436(Journal) (5048401-N )
DOI: 10.1093/neuonc/4.2.102(Journal)
==========================================================

Created: 2017-10-13 11:20:44.0
ConfID: 5051431
CauseID: 1415932983
OtherID: 63385536, 233345263, 1415932983
JT: Neuro-Oncology
MD: Kunkel, 3 ,2,82,2001,Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas
DOI: 10.1215/S1522851700000442(Journal) (5051431-N )
DOI: 10.1093/neuonc/3.2.82(Journal)
==========================================================

Created: 2017-10-13 15:03:20.0
ConfID: 5051446
CauseID: 1415940904
OtherID: 63385536, 233345263, 1415940904
JT: Neuro-Oncology
MD: Visted, 3 ,3,201,2001,Cell encapsulation technology as a therapeutic strategy for CNS malignancies
DOI: 10.1215/S1522851700000648(Journal) (5051446-N )
DOI: 10.1093/neuonc/3.3.201(Journal)
==========================================================

Created: 2017-10-13 06:06:54.0
ConfID: 5051447
CauseID: 1415920097
OtherID: 63385536, 233345263, 1415920097
JT: Neuro-Oncology
MD: Ding, 3 ,1,1,2001,Expression and hypoxic regulation of angiopoietins in human astrocytomas
DOI: 10.1215/S1522851700000314(Journal) (5051447-N )
DOI: 10.1093/neuonc/3.1.1(Journal)
==========================================================

Created: 2017-10-13 06:17:54.0
ConfID: 5051448
CauseID: 1415920766
OtherID: 63385536, 1415920766
JT: Neuro-Oncology
MD: Westphal, 5 ,2,79,2003,A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
DOI: 10.1215/S1522851702000236(Journal) (5051448-N )
DOI: 10.1093/neuonc/5.2.79(Journal)
==========================================================

Created: 2017-10-13 17:44:19.0
ConfID: 5053983
CauseID: 1415946321
OtherID: 63385536, 1415946321
JT: Neuro-Oncology
MD: Levin, 1 ,1,69,1999,Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are heading
DOI: 10.1215/S1522851798000088(Journal) (5053983-N )
DOI: 10.1093/neuonc/1.1.69(Journal)
==========================================================

Created: 2017-10-13 13:31:48.0
ConfID: 5053993
CauseID: 1415936703
OtherID: 63385536, 233345263, 1415936703
JT: Neuro-Oncology
MD: Kleihues, 1 ,1,44,1999,Primary and secondary glioblastomas: From concept to clinical diagnosis
DOI: 10.1215/S1522851798000180(Journal) (5053993-N )
DOI: 10.1093/neuonc/1.1.44(Journal)
==========================================================

Created: 2017-10-13 13:47:19.0
ConfID: 5053994
CauseID: 1415937131
OtherID: 63385536, 1415937131
JT: Neuro-Oncology
MD: Wiltshire, 2 ,3,164,2000,Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification
DOI: 10.1215/S1522851700000156(Journal) (5053994-N )
DOI: 10.1093/neuonc/2.3.164(Journal)
==========================================================

Created: 2017-10-13 04:41:52.0
ConfID: 5056142
CauseID: 1415915125
OtherID: 63385536, 1415915125
JT: Neuro-Oncology
MD: Glick, 3 ,4,258,2001,Immunotherapy Task Force For Malignant Brain Tumors April 21, 2001, Toronto, Ontario
DOI: 10.1215/S152285170100031X(Journal) (5056142-N )
DOI: 10.1093/neuonc/3.4.258(Journal)
==========================================================

Created: 2017-10-13 13:48:26.0
ConfID: 5056155
CauseID: 1415937156
OtherID: 63385536, 233345263, 1415937156
JT: Neuro-Oncology
MD: Schwarz, 4 ,3,187,2002,Intravascular lymphomatosis presenting with a conus medullaris syndrome mimicking disseminated encephalomyelitis
DOI: 10.1215/S1522851701000588(Journal) (5056155-N )
DOI: 10.1093/neuonc/4.3.187(Journal)
==========================================================

Created: 2017-10-13 17:08:20.0
ConfID: 5057881
CauseID: 1415945171
OtherID: 63385536, 1415945171
JT: Neuro-Oncology
MD: Jukich, 3 ,3,141,2001,Trends in incidence of primary brain tumors in the United States, 1985-1994
DOI: 10.1215/S1522851700000557(Journal) (5057881-N )
DOI: 10.1093/neuonc/3.3.141(Journal)
==========================================================

Created: 2017-10-13 12:14:54.0
ConfID: 5057889
CauseID: 1415934552
OtherID: 63385536, 1415934552
JT: Neuro-Oncology
MD: Yokoyama, 3 ,1,22,2001,Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro
DOI: 10.1215/S1522851700000260(Journal) (5057889-N )
DOI: 10.1093/neuonc/3.1.22(Journal)
==========================================================

Created: 2017-10-13 05:35:29.0
ConfID: 5059320
CauseID: 1415918449
OtherID: 63385536, 1415918449
JT: Neuro-Oncology
MD: Meyers, 5 ,2,89,2003,Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression
DOI: 10.1215/S1522851702000261(Journal) (5059320-N )
DOI: 10.1093/neuonc/5.2.89(Journal)
==========================================================

Created: 2017-10-13 07:10:12.0
ConfID: 5059330
CauseID: 1415923359
OtherID: 63385536, 233345263, 1415923359
JT: Neuro-Oncology
MD: Mahoney, 2 ,4,213,2000,Carboplatin is effective therapy for young children with progressive optic pathway tumors: A Pediatric Oncology Group phase II study
DOI: 10.1215/S1522851700000223(Journal) (5059330-N )
DOI: 10.1093/neuonc/2.4.213(Journal)
==========================================================

Created: 2012-03-13 11:13:39.0
ConfID: 5059342
CauseID: 1349651443
OtherID: 63385536, 233345263, 1349651443
JT: Neuro-Oncology
MD: Bigner, 1 ,1,26,1999,Preface
DOI: 10.1215/S152285179810025X(Journal) (5059342-N )
DOI: 10.1093/neuonc/1.1.26(Journal)
==========================================================

Created: 2017-10-13 04:28:37.0
ConfID: 5059343
CauseID: 1415914426
OtherID: 63385536, 233345263, 1415914426
JT: Neuro-Oncology
MD: Gollmer, 2 ,2,80,2000,Expression of vascular endothelial growth factor-b in human astrocytoma
DOI: 10.1215/S1522851799000332(Journal) (5059343-N )
DOI: 10.1093/neuonc/2.2.80(Journal)
==========================================================

Created: 2017-10-13 04:28:31.0
ConfID: 5060520
CauseID: 1415914419
OtherID: 63385536, 1415914419
JT: Neuro-Oncology
MD: Fults, 2 ,2,71,2000,Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas
DOI: 10.1215/S1522851799000289(Journal) (5060520-N )
DOI: 10.1093/neuonc/2.2.71(Journal)
==========================================================

Created: 2017-10-13 14:42:05.0
ConfID: 5060521
CauseID: 1415940151
OtherID: 63385536, 1415940151
JT: Neuro-Oncology
MD: Hukin, 4 ,4,253,2002,Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors
DOI: 10.1215/S1522851701000680(Journal) (5060521-N )
DOI: 10.1093/neuonc/4.4.253(Journal)
==========================================================

Created: 2017-10-13 12:54:40.0
ConfID: 5060522
CauseID: 1415935644
OtherID: 63385536, 1415935644
JT: Neuro-Oncology
MD: Kim, 4 ,3,165,2002,Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences
DOI: 10.1215/S1522851701000606(Journal) (5060522-N )
DOI: 10.1093/neuonc/4.3.165(Journal)
==========================================================

Created: 2017-10-13 05:09:51.0
ConfID: 5063339
CauseID: 1415916568
OtherID: 63385536, 1415916568
JT: Neuro-Oncology
MD: Geoerger, 2 ,2,103,2000,Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts
DOI: 10.1215/S1522851799000514(Journal) (5063339-N )
DOI: 10.1093/neuonc/2.2.103(Journal)
==========================================================

Created: 2017-10-13 11:19:50.0
ConfID: 5063703
CauseID: 1415932933
OtherID: 63385536, 1415932933
JT: Neuro-Oncology
MD: Chamberlain, 1 ,2,120,1999,Epidural spinal cord compression: A single institution''s retrospective experience
DOI: 10.1215/S1522851798000027(Journal) (5063703-N )
DOI: 10.1093/neuonc/1.2.120(Journal)
==========================================================

Created: 2017-10-13 17:38:41.0
ConfID: 5064639
CauseID: 1415946051
OtherID: 63385536, 233345263, 1415946051
JT: Neuro-Oncology
MD: Schold, 2 ,1,34,2000,A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: A North American Brain Tumor Consortium study
DOI: 10.1215/S1522851799000265(Journal) (5064639-N )
DOI: 10.1093/neuonc/2.1.34(Journal)
==========================================================

Created: 2017-11-29 09:28:14.0
ConfID: 5306688
CauseID: 1417633954
OtherID: 1417633430, 1417633954
JT: Neuro-Oncology
MD: null, 19 ,12,1701,2017,Corrigenda
DOI: 10.1093/neuonc/nox102(Journal) (5306688-N )
DOI: 10.1093/neuonc/nox110(Journal)